相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/beta-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth
Ninib Baryawno et al.
CANCER RESEARCH (2010)
Recent Advances in Anti-Survivin Treatments for Cancer
R. K. Kanwar et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Glycogen synthase kinases-3β controls differentiation of malignant glioma cells
Yan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth
P. Pu et al.
CANCER GENE THERAPY (2009)
Mcl-1 is a potential therapeutic target in multiple types of cancer
C. Akgul
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Rosiglitazone Reduces the Development and Rupture of Experimental Aortic Aneurysms
Alun Jones et al.
CIRCULATION (2009)
Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Katsuyoshi Miyashita et al.
CLINICAL CANCER RESEARCH (2009)
Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies
Nikhil G. Thaker et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas
Gangadhara Reddy Sareddy et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
Serdar Korur et al.
PLOS ONE (2009)
Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Gordon Shore et al.
CURRENT MOLECULAR MEDICINE (2008)
Combination therapy for malignant glioma based on PTEN status
Javier Gonzalez et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
Michal O. Nowicki et al.
NEURO-ONCOLOGY (2008)
Molecularly targeted therapy for malignant glioma
Sith Sathornsumetee et al.
CANCER (2007)
Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization
Qingqing Ding et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3β activity and associates with poor prognosis in human breast cancer
Qingqing Ding et al.
CANCER RESEARCH (2007)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Riccardo Fodde et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Targeting multiple arms of the apoptotic regulatory machinery
Yun Dai et al.
CANCER RESEARCH (2007)
Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo
H Momota et al.
CANCER RESEARCH (2005)
Activated JNK brings about accelerated apoptosis of Bcl-2-overexpressing C6 glioma cells on treatment with tamoxifen
MS Moodbidri et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas
AM Spence et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
A Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis
ZB You et al.
JOURNAL OF CELL BIOLOGY (2002)
Mechanisms of tamoxifen-induced apoptosis
S Mandlekar et al.
APOPTOSIS (2001)
分享论文
